MOHAMMED MILHEM

🇦🇺Australia
Ownership
-
Employees
-
Market Cap
-
Website

Chlorpromazine and Standard of Care in Glioblastoma

First Posted Date
2022-01-13
Last Posted Date
2023-08-29
Lead Sponsor
Mohammed Milhem
Target Recruit Count
10
Registration Number
NCT05190315
Locations
🇺🇸

University of Iowa Hospitals & Clinics, Iowa City, Iowa, United States

High Dose Ascorbate With Preoperative Radiation in Patients With Locally Advanced Soft Tissue Sarcomas

Phase 1
Completed
Conditions
Interventions
First Posted Date
2018-04-26
Last Posted Date
2024-06-27
Lead Sponsor
Mohammed Milhem
Target Recruit Count
25
Registration Number
NCT03508726
Locations
🇺🇸

University of Iowa Hospitals and Clinics, Iowa City, Iowa, United States

Anti-Osteoclast Therapy as Neoadjuvant in Treatment of Chondrosarcoma - Phase 1b Trial

Phase 1
Active, not recruiting
Conditions
Interventions
First Posted Date
2017-06-02
Last Posted Date
2024-05-30
Lead Sponsor
Mohammed Milhem
Target Recruit Count
17
Registration Number
NCT03173976
Locations
🇺🇸

University of Iowa Hospitals and Clinics, Iowa City, Iowa, United States

Decitabine and Gemcitabine for Pancreatic Cancer and Sarcoma

First Posted Date
2016-11-08
Last Posted Date
2023-07-28
Lead Sponsor
Mohammed Milhem
Target Recruit Count
36
Registration Number
NCT02959164
Locations
🇺🇸

University of Iowa Hospitals and Clinics, Iowa City, Iowa, United States

© Copyright 2024. All Rights Reserved by MedPath